| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Peter A Demopulos MD is Director at OMER. The disclosed holdings are worth an estimated $3.8M at current prices.
Net of sales, the OMER filings show accumulation of 13,962 shares.
Peter A Demopulos MD has 17 Form 4 filings on record from May 2015 to June 2026, all as Director at Omeros (OMER), 2015–2026.
The 18 reported transactions were 13 option or other derivative awards, 3 option exercises and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $66K and no sales.
The largest open-market purchase was 3,962 shares of OMER at an average $12.68 on September 4, 2015, about $50K.